WHO-GMP-ISO Certified Manufacturer Verified Company Quick Response · Fast Dispatch PCD Pharma Franchise

Ovireg SR 5 Tablets

● In Stock Rx Required
Gynecology Oncology Tablet

Ovireg SR 5 Tablets contain Letrozole 5 mg SR, an aromatase inhibitor. Available from Pharmakon Lifesciences, Karnal, for PCD franchise and third-party manufacturing.

Dosage Form Tablet
Composition Letrozole 5 mg SR
Packing 10x1x5 Blister (Mono Carton)
MRP On Request
Available For: ✓ PCD Pharma Franchise ✓ Third-Party Mfg.
Interested in this product? < 24 hours
WhatsApp
Verified Manufacturer

Product Description

Ovireg SR 5 Tablets contain Letrozole 5 mg SR, an aromatase inhibitor. Available from Pharmakon Lifesciences, Karnal, for PCD franchise and third-party manufacturing.

Indications

Ovulation induction in infertility (as prescribed)
Hormone-receptor-positive breast cancer

Dosage

As directed by the physician.

Side Effects

Nausea, breast tenderness, headache, spotting or mood changes may occur. Use only under the supervision of a gynaecologist.

Storage Instructions

Store in a cool, dry place below 30°C, protected from light and moisture.
Keep out of the reach of children.

Availability

Ovireg SR 5 Tablets is available for PCD Pharma Franchise distribution and Third-Party Contract Manufacturing across India. Reach out to the manufacturer for pricing, MOQ and territory details.

Pharmaceutical Specifications

Product NameOvireg SR 5 Tablets
Dosage FormTablet
CompositionLetrozole 5 mg SR
StrengthN/A
Packing10x1x5 Blister (Mono Carton)
MRPOn Request
PrescriptionRx Required
Manufactured byPharmakon Lifesciences, Karnal
Delivery Time15–25 working days
CertificationsISO 9001:2015 · WHO-GMP · Verified Company

Company Information